Search Results 771-780 of 17319 for Bulimia

  1. Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia - Mayo Clinic

    The purpose of this study is to test any good and bad effects of adding the drug Blinatumomab to different doses of standard combination of chemotherapy drugs.

  2. Shear Wave Elastograph and Contrast Enhanced Ultrasound for the Treatment of Lymphedema - Mayo Clinic

    About this study. Lymphaticovenous anstomosis is an effective surgery to treat lymphedema in the upper extremities secondary to cancer treatment.

  3. Patient Stories - Deb A. Baumgarten, M.D., M.P.H. - Mayo Clinic

    Have 2X the impact! ... Make a gift that can go twice as far to advance healthcare research. Give Today.

  4. Application for Self-Monitoring of Cardiovascular Risk - Mayo Clinic

    About this study. Patients who recently suffered a heart attack will use a smart-phone/computer application during cardiac rehabilitation to reduce their ...

  5. Emily Brown, R.D.N., L.D. - Mayo Clinic

    Have 2X the impact! ... Make a gift that can go twice as far to advance healthcare research. Give Today.

  6. Selective Serotonin Inhibitor-Induced Changes in the Gut Microbiome in Depression - Mayo Clinic

    The purpose of this study is to uncover the main effects of selective serotonin inhibitor-induced (SSRI) therapy on the human microbiota, the relationship to ...

  7. Organ Transplantation Archives - Mayo Clinic News Network

  8. T-cell lymphoma - Symptoms and causes - Mayo Clinic

    Find out more about the symptoms, diagnosis and treatment of this type of non-Hodgkin lymphoma.

  9. Patient Stories - Robert C. Murphy, M.D., Ph.D. - Mayo Clinic

    Robert C. Murphy, M.D., Ph.D. Radiologist. Request an Appointment · Overview · Publications ...

  10. Neurobiology of Alcoholism and Drug Addiction: Doo-Sup Choi

    Mayo Clinic's Neurobiology of Alcoholism and Drug Addiction Lab led by Doo-Sup Choi, Ph.D., identifies and validates therapeutic targets for alcohol use ...